OPtimizing Technology to Improve Medication Adherence and Blood Pressure Control

What this Trial Is About

Hypertension (HTN) significantly impacts African American (AA) older adults more than any other U.S. racial group, contributing to higher rates of disability, death, and healthcare use. This trial evaluates a technology-based approach called OPTIMA-BP to support self-management of HTN and improve blood pressure control over 12 months. It focuses on AA adults aged 50 and older, aiming to reduce health disparities and improve quality of life by targeting medication adherence and lifestyle behaviors. Participants are randomly assigned to either receive the OPTIMA-BP intervention immediately for 6 months followed by a 6-month observation period, or to a 6-month waitlist control before receiving the intervention for 6 months. The OPTIMA-BP intervention includes six weekly web-based education sessions about hypertension management, access to the Medisafe medication management app with reminders and feedback, home blood pressure monitoring twice daily twice a week, nurse counseling sessions for support, and coordination with their physician to optimize hypertension treatment. During the study, participants monitor their blood pressure at home and keep tracking logs. They also complete assessments of blood pressure control and health-related quality of life at baseline and 6 months. Researchers will collect biological risk markers and measure blood pressure control below 130/80 mmHg. The trial involves regular follow-up, support, and data collection over the 12-month period to evaluate the effectiveness of the intervention in improving self-management and health outcomes.

OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)